Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A recipe for proteomics diagnostic test development: the OVA1 test, from biomarker discovery to FDA clearance.

Literature DB >> 20110452

A recipe for proteomics diagnostic test development: the OVA1 test, from biomarker discovery to FDA clearance.

Eric T Fung¹.
1. Vermillion, Inc., Fremont, CA.

Abstract

Mesh：

Substances：
Biomarkers, Tumor

Year: 2010 PMID： 20110452 DOI： 10.1373/clinchem.2009.140855

Source DB: PubMed Journal: Clin Chem ISSN： 0009-9147 Impact factor: 8.327

Keyword Cloud
Cited

× No keyword cloud information.

34 in total

Review 1. Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers.

Authors: Steven L Wood; Margaret A Knowles; Douglas Thompson; Peter J Selby; Rosamonde E Banks
Journal: Nat Rev Urol Date: 2013-02-26 Impact factor: 14.432

Review 2. Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer.

Authors: Norihisa Uemura; Tadashi Kondo
Journal: World J Gastrointest Pathophysiol Date: 2014-08-15

3. Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

Authors: A Oaknin; R Guarch; P Barretina; D Hardisson; A González-Martín; X Matías-Guiu; A Pérez-Fidalgo; B Vieites; I Romero; J Palacios
Journal: Clin Transl Oncol Date: 2017-08-16 Impact factor: 3.405

4. Maintenance therapy in ovarian cancer: Molecular basis and therapeutic approach.

Authors: Monica Binaschi; Cecilia Simonelli; Cristina Goso; Mario Bigioni; Carlo Alberto Maggi
Journal: Exp Ther Med Date: 2011-01-14 Impact factor: 2.447

5. Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.

Authors: Daniel W Cramer; Robert C Bast; Christine D Berg; Eleftherios P Diamandis; Andrew K Godwin; Patricia Hartge; Anna E Lokshin; Karen H Lu; Martin W McIntosh; Gil Mor; Christos Patriotis; Paul F Pinsky; Mark D Thornquist; Nathalie Scholler; Steven J Skates; Patrick M Sluss; Sudhir Srivastava; David C Ward; Zhen Zhang; Claire S Zhu; Nicole Urban
Journal: Cancer Prev Res (Phila) Date: 2011-03

6. Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis.

Authors: W C S Cho; T T Yip; W W Cheng; J S K Au
Journal: Br J Cancer Date: 2010-05-25 Impact factor: 7.640

7. Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients.

Authors: John D Andersen; Kristin Lm Boylan; Ronald Jemmerson; Melissa A Geller; Benjamin Misemer; Katherine M Harrington; Starchild Weivoda; Bruce A Witthuhn; Peter Argenta; Rachel Isaksson Vogel; Amy Pn Skubitz
Journal: J Ovarian Res Date: 2010-09-10 Impact factor: 4.234